BioSpace News Archive

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first cohort has been dosed in the Phase 1 study of the subcutaneous formulation of CDX-0159 in healthy volunteers.

Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at The United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

Medidata, a Dassault Systèmes company, and Labcorp Drug Development, a global company providing clinical laboratory and end-to-end drug development services, today announced they have entered into an agreement using the Medidata Sensor Cloud.

Longeveron Inc. has entered into an agreement with Kinesiometrics Inc., (“Kinesiometrics”) to provide a cutting-edge, digital data-driven solution for objective real-time measurement of functional capacity and quality of life in Longeveron’s clinical studies.

The 46th edition of the Toronto International Film Festival features 10 days of exceptional international and Canadian cinema with close to 200 films in its Official Selection, unparalleled events featuring acclaimed industry guests, and TIFF’s Industry Conference.

TG Therapeutics, Inc., today recapped the schedule of upcoming data presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL), being held virtually September 17 – 20, 2021.

Paul Brennan, NervGen’s President and CEO, will provide an overview of the Company’s operations and the development plans for its lead compound, NVG-291.

Satellos scientists are developing small molecule drugs with the goal of restoring faulty regeneration and repair observed in the muscles of patients with Duchenne and potentially other degenerative and age-related muscle disorders.

iTolerance, Inc., a regenerative medicine company enabling tissue, organoid or cell therapy without the need for life-long immunosuppression, announced the formation of its Scientific Advisory Board and the appointment of its inaugural members, Andrés J. García, PhD, F.B.S.E., Haval Shirwan, PhD, and James Markmann, MD, PhD.

Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), hosted its 16th CareKinesis Clinical Advisory Panel (CAP) Meeting, September 9-10, 2021, bringing together Program of All-Inclusive Care for the Elderly (PACE) medical directors from across the country.